NEW YORK, March 18, 2014 /PRNewswire/ --
CytRx Corporation
Lifshitz & Miller announces that a class action was
filed in the United States District Court for the Central District
of California, alleging CytRx
Corporation ("CYTR") issued false and misleading statements during
the period between November 22, 2013
and March 13, 2014.
Specifically, defendants made false and/or misleading statements
and/or failed to disclose that that numerous articles praising
CytRx stock were paid stock promotions.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
DURECT Corporation
Lifshitz & Miller announces that it is investigating
potential claims against the officers and board of DURECT
Corporation ("DRRX"). On February 12,
2014, the Company disclosed that the FDA had issued a
Complete Response Letter for the Company's product candidate,
POSIDUR. The Complete Response Letter means that the FDA will
not approve POSIDUR's application for marketing approval in its
current form.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Hastings Entertainment, Inc.
Lifshitz & Miller announces an investigation into
possible breaches of fiduciary duty in connection with the proposed
sale of Hastings Entertainment, Inc. ("HAST") to Draw Another
Circle, LLC and Hendrix Acquisition Corp., which are each
wholly-owned, directly or indirectly, by Joel Weinshanker in an all-cash transaction for
$3.00 per share or approximately
$21.4 million.
Lifshitz & Miller's investigation is focused on whether the
HAST directors are acting in shareholders best interest.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Immunomedics, Inc.
Lifshitz & Miller announces that a class action was
filed in the United States District Court for the District of
New Jersey, alleging Immunomedics,
Inc. ("IMMU") issued false and misleading statements during the
period between May 9, 2013 and
October 9, 2013. Specifically,
defendants made false and/or misleading statements and/or failed to
disclose that the Company and Takeda-Nycomed were embroiled in an
on-going dispute regarding what Immunomedics considered to be an
unacceptable delay in the development of Veltuzumab.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
NII Holdings, Inc.
Lifshitz & Miller announces that a class action was
filed in the United States District Court for the Eastern District
of Virginia, alleging NII
Holdings, Inc. ("NIHD") issued false and misleading statements
during the period between February 25,
2010 and February 27,
2014. Specifically, defendants made false and/or misleading
statements and/or failed to disclose that NIHD and NII Capital
improperly concealed the Company's failing efforts to modernize its
telecommunications network and expand its subscriber base.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
ATTORNEY ADVERTISING. © 2014 Lifshitz &
Miller. The law firm responsible for this advertisement is
Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)
493-9780. Prior results do not guarantee or predict a similar
outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
SOURCE Lifshitz & Miller Law Firm